These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 773339)

  • 1. Immunoglobulin E. Current status and clinical laboratory applications.
    Ishizaka K; Ishizaka T
    Arch Pathol Lab Med; 1976 Jun; 100(6):289-92. PubMed ID: 773339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological events at the surface of basophil granulocytes and mast cells which induce degranulation.
    Ishizaka T; Ishizaka K
    Scand J Respir Dis Suppl; 1977; 98():13-22. PubMed ID: 72408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of reaginic hypersensitivity and immunotherapy.
    Ishizaka K; Ishizaka T
    Lung; 1978; 155(1):3-22. PubMed ID: 351300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic significance of disulfide bonds in human IgE molecules.
    Takatsu K; Ishizaka T; Ishizaka K
    J Immunol; 1975 Jun; 114(6):1838-45. PubMed ID: 47881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
    Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
    Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dean's lecture. Immunoglobulin E and reaginic hypersensitivity.
    Ishizaka K
    Johns Hopkins Med J; 1974 Aug; 135(2):67-90. PubMed ID: 4136622
    [No Abstract]   [Full Text] [Related]  

  • 8. Does IgE bind to and activate eosinophils from patients with allergy?
    Kita H; Kaneko M; Bartemes KR; Weiler DA; Schimming AW; Reed CE; Gleich GJ
    J Immunol; 1999 Jun; 162(11):6901-11. PubMed ID: 10352312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy.
    Lichtenstein LM; Ishizaka K; Norman PS; Sobotka AK; Hill BM
    J Clin Invest; 1973 Feb; 52(2):472-82. PubMed ID: 4119162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quantification of IgE antibody specific for ragweed Antigen E (AgE) on the basophil surface in patients with ragweed pollenosis.
    Zeiss CR; Pruzansky JJ; Levitz D; Wang J
    Immunology; 1978 Aug; 35(2):237-46. PubMed ID: 86501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic and cellular changes accompanying the therapy of pollen allergy.
    Levy DA; Lichtenstein LM; Goldstein EO; Ishizaka K
    J Clin Invest; 1971 Feb; 50(2):360-9. PubMed ID: 4099843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative relationships between IgE antibody and blocking antibodies specific for antigen E in patients given immunotherapy with ragweed antigen E.
    Zeiss CR; Metzger WJ; Levitz D
    Clin Exp Immunol; 1977 May; 28(2):250-5. PubMed ID: 872449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mast-cell and basophil function and survival by IgE.
    Kawakami T; Galli SJ
    Nat Rev Immunol; 2002 Oct; 2(10):773-86. PubMed ID: 12360215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
    Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
    J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
    Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
    Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
    Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
    Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daëron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of immunotherapy on humoral and cellular responses in ragweed hayfever.
    Evans R; Pence H; Kaplan H; Rocklin RE
    J Clin Invest; 1976 May; 57(5):1378-85. PubMed ID: 57122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.